Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets
Phase 1
Completed
- Conditions
- Bladder Cancer
- Interventions
- Drug: APL-1202+APL-1501 ER Tablets 3+APL-1501 ER Tablets 2Drug: APL-1501 ER Tablets 3+APL-1202+APL-1501 ER Tablets 2
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2021-06-30
- Lead Sponsor
- Asieris Pharmaceuticals (AUS) Pty Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT04601766
- Locations
- 🇦🇺
Scientia clinical research, Randwick, New South Wales, Australia
News
No news found